Elisa Camela, Alessia Villani, Sonia Sofia Ocampo Garza, Claudia Costa, Gabriella Fabbrocini, Matteo Megna, . . . Massimiliano Scalvenzi. (2023). Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire. Mattioli1885.
Chicago Style (17th ed.) CitationElisa Camela, Alessia Villani, Sonia Sofia Ocampo Garza, Claudia Costa, Gabriella Fabbrocini, Matteo Megna, Luca Potestio, Angelo Ruggiero, and Massimiliano Scalvenzi. Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire. Mattioli1885, 2023.
MLA (9th ed.) CitationElisa Camela, et al. Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire. Mattioli1885, 2023.